When fertility test technology is used to determine the likelihood of pregnancy, it can’t provide any meaningful information about your ability to have a child.

But a new study suggests that the technology can provide some clues about the likelihood that you will have one.

“If the test shows you’re fertile, you’re probably pregnant,” says Kristina Koehler, a reproductive medicine physician at the University of Utah Medical Center in Salt Lake City.

“That’s why I’m always telling my patients, ‘You’re fertile now.’

It’s not a test you can tell when you’re not pregnant.”

Koehler and her colleagues recently presented the results of a study to the American College of Obstetricians and Gynecologists, and they describe how they used the test to find that “if you’re a fertile woman, you probably are,” as well as to determine if you have a high risk of pregnancy and/or miscarriage.

The test is available at most health care providers and online.

They also reported their findings in a study published last month in the journal Obstetrics & Gynecology.

The test, called the Fertilization Indicator, or FIV, is a simple test that uses a pulse of blood to determine how much of a person’s blood you’re producing.

It measures a person by measuring their “fertile” or “viable” blood, and it can be used to help women with medical conditions like pre-eclampsia and ovarian cysts, or women who may be pregnant and are considering getting pregnant.

A positive test results in about 0.1% of women who test positive, and a negative test results less than 1% of the time.

Koehl’s team used the FIV test to collect data from more than 11,000 women in the United States who were either pregnant or planning to get pregnant and wanted to know if they were at a high or low risk of having a child with a low probability of success.

They did so by randomly assigning participants to one of three groups: 1) those who tested positive for FIV; 2) those with a high FIV rate; or 3) those without a high rate of FIV.

The researchers asked participants about their past fertility history and the factors that might be causing their fertility to drop.

The groups were separated by age, race, education, and other factors that would influence their fertility, and the women were then randomly assigned to one group or the other.

In one of the groups, the researchers compared the women who tested negative for Fiv to those who were at or above a certain level of fertility.

They found that the women with low fertility were more likely to have had a pregnancy, had a miscarriage, and had a low-FIV rate.

The researchers then conducted a statistical analysis to determine what factors might have influenced their fertility.

The FIV results showed that there was no significant difference between groups.

Koeshler says that these results may help explain why there are so many women with high fertility who have low FIV rates.

“The more people who are fertile, the more likely they are to have an abortion,” she says.

“There’s also the possibility that if you are fertile you’re also having a high-Fiv rate, so you have more potential of getting pregnant.”

While the Fiv test is used widely in fertility testing, Koehl says that it should not be used as a diagnostic tool.

It should be used with caution.

“I think it’s important to make sure that we understand the relationship between FIV and the outcomes that you might be looking at with the Fertility Indicator,” she explains.

“We need to understand the context of that relationship.”

In addition to the implications of low fertility rates, Koeshler notes that the Fitt test can be misused.

“It could be used in women who are not pregnant or who are planning to be pregnant, and there’s not really any way to know that they’re not having a fertilized ovum or embryo,” she adds.

“They’re just saying, ‘OK, I’m fertile.'”

But even if a woman is using the FibreShot test, she is still giving her body the opportunity to make decisions about when to become pregnant.

“The best way to use the Fitch is to have your body make a decision,” Koeshl says.